Displaying 1 - 20 of 23
  • Print
Contract Number Brand Code Brand Name Active Ingredient Trade Name Package Size Formulary Category Pkg Price Unit Price Unit Description Max. Reimbursable Quantity / Month Package Description Manufacturer Code Manufacturer Name Agent Code Agent Name Benefit Therapeutic Code Therapeutic Desc Drug Contract Start Date Drug Contract End Date Status Description Default Route Max Repeats Therapeutic Head Amend Date
40 A2313 NEURONTIN 300MG CAP (PFI/STO) GABAPENTIN GABAPENTIN NEURONTIN 100'S C 150.08 1.50 CAPSULE 0 CAP PFI PFIZER CORPORATION STO BRYDEN STOKES LTD B 281292 ANTICONVULSANTS MISCELLANEOUS 2022-04-01 2024-03-31 Oral 0 CENTRAL NERVOUS SYSTEM DRUGS
41 A2313 NEURONTIN 300MG CAP (PFI) GABAPENTIN (C) GABAPENTIN NEURONTIN 100'S C 151.44 1.5144 CAP 180 BOX PFI PFIZER CORPORATION STO BRYDEN STOKES LTD B 281292 ANTICONVULSANTS MISCELLANEOUS 2024-04-01 2026-03-31 ORAL 6 ANTICONVULSANTS MISCELLANEOUS
40 A2314 APO-GABAPENTIN 300MG CAP (APO/COL) GABAPENTIN APO-GABAPENTIN 100'S A 11.77 0.12 CAPSULE 180 CAP APO APOTEX INC. COL COLLINS LTD B 281292 ANTICONVULSANTS MISCELLANEOUS 2022-04-01 2024-03-31 Oral 6 CENTRAL NERVOUS SYSTEM DRUGS
42 A2314 APO-GABAPENTIN 300MG CAP (APO) GABAPENTIN APO-GABAPENTIN 100'S C 13.21 0.13 CAP 180 BOTT APO APOTEX INC. COL AVENTA BARBADOS B 281292 ANTICONVULSANTS MISCELLANEOUS 2026-04-01 ORAL 6 ANTICONVULSANTS MISCELLANEOUS
42 A231AE GABAPENTIN 300MG CAP (FSB) GABAPENTIN GABAPENTIN 100'S A 7.04 0.07 CAP 180 FSB FLAGSHIP BIOTECH STO BRYDEN STOKES LTD B 281292 ANTICONVULSANTS MISCELLANEOUS 2026-04-01 Add to Contract as Cat A ORAL 6 ANTICONVULSANTS MISCELLANEOUS 2026-03-05
40 A231AG GABAPENTIN 300MG CAP (KWA/ATB) GABAPENTIN GABAPENTIN 10X10 A 11.66 0.12 CAPSULE 180 CAP KWA KWALITY PHARMACEUTICALS ATB ANSA TRADING BARBADOS LTD B 281292 ANTICONVULSANTS MISCELLANEOUS 2022-04-01 2024-03-31 Oral 6 CENTRAL NERVOUS SYSTEM DRUGS
41 A231AY GABAPENTIN 300MG CAP (FSB) GABAPENTIN GABAPENTIN 100'S A 8.18 0.0818 CAP 180 BOX FSB FLAGSHIP BIOTECH ATB ANSA TRADING BARBADOS LTD B 281292 ANTICONVULSANTS MISCELLANEOUS 2024-04-01 2026-03-31 ORAL 6 ANTICONVULSANTS MISCELLANEOUS
42 A231B GABANIL 300MG CAP (REM) GABAPENTIN GABAPENTIN GABANIL 5X10 C 9.11 0.18 CAP 180 BOTT REM REMEDICA LTD SBI MASSY DISTRIBUTION (BDOS) LTD B 281292 ANTICONVULSANTS MISCELLANEOUS 2026-04-01 ORAL 6 ANTICONVULSANTS MISCELLANEOUS
40 A231BE GABAPENTIN 300MG CAP (AUR/AHI) GABAPENTIN GABAPENTIN 100'S A 11.69 0.12 CAPSULE 180 CAP AUR AUROCHEM LABORATORIES AHI ARMSTRONG HEALTHCARE INC B 281292 ANTICONVULSANTS MISCELLANEOUS 2022-04-01 2024-03-31 Price Change Oral 6 CENTRAL NERVOUS SYSTEM DRUGS 2022-04-01
41 A231BG APO-GABAPENTIN 300MG CAP (APO) GABAPENTIN APO-GABAPENTIN 100'S A 9.7 0.097 CAP 180 BOTT APO APOTEX INC. ATB ANSA TRADING BARBADOS LTD B 281292 ANTICONVULSANTS MISCELLANEOUS 2024-04-01 2026-03-31 ORAL 6 ANTICONVULSANTS MISCELLANEOUS
41 A231BL GABAPENTIN 300MG CAP (MCP) GABAPENTIN GABAPENTIN 10X10 A 9.24 0.0924 CAP 180 BOX MCP MACLEODS PHARMACEUTICALS LTD AHI ARMSTRONG HEALTHCARE INC B 281292 ANTICONVULSANTS MISCELLANEOUS 2024-04-01 2026-03-31 ORAL 6 ANTICONVULSANTS MISCELLANEOUS
42 A231BL GABAPENTIN 300MG CAP (MCP) GABAPENTIN GABAPENTIN 10X10 A 9.32 0.09 CAP 180 BLIS MCP MACLEODS PHARMACEUTICALS LTD AHI ARMSTRONG HEALTHCARE INC B 281292 ANTICONVULSANTS MISCELLANEOUS 2026-04-01 ORAL 6 ANTICONVULSANTS MISCELLANEOUS
42 A231BP NEURONTIN 300MG CAP (PFI) GABAPENTIN GABAPENTIN NEURONTIN 100'S C 151.44 1.51 CAP 180 BLIS PFI PFIZER CORPORATION COL AVENTA BARBADOS B 281292 ANTICONVULSANTS MISCELLANEOUS 2026-04-01 ORAL 6 ANTICONVULSANTS MISCELLANEOUS
42 A231BQ GABALGIA 300MG CAP (ANC) GABAPENTIN GABAPENTIN GABALGIA 10X10 A 7.34 0.07 CAP 180 BLIS ANC AEONIM HEALTHCARE SBI MASSY DISTRIBUTION (BDOS) LTD B 281292 ANTICONVULSANTS MISCELLANEOUS 2026-04-01 ORAL 6 ANTICONVULSANTS MISCELLANEOUS
40 A231D NEURONTIN 300MG CAP (PFI/SBI) GABAPENTIN GABAPENTIN NEURONTIN 100'S C 150.08 1.50 CAPSULE 0 CAP PFI PFIZER CORPORATION SBI MASSY DISTRIBUTION (BDOS) LTD B 281292 ANTICONVULSANTS MISCELLANEOUS 2022-04-01 2024-03-31 Oral 0 CENTRAL NERVOUS SYSTEM DRUGS
41 A231D NEURONTIN 300MG CAP (PFI) GABAPENTIN (C) GABAPENTIN NEURONTIN 100'S C 151.44 1.5144 CAP 180 BOX PFI PFIZER CORPORATION SBI MASSY DISTRIBUTION (BDOS) LTD B 281292 ANTICONVULSANTS MISCELLANEOUS 2024-04-01 2026-03-31 ORAL 6 ANTICONVULSANTS MISCELLANEOUS
40 A231H GABANIL 300MG CAP (REM/SBI) GABAPENTIN GABAPENTIN GABANIL 5X10 C 9.51 0.19 CAPSULE 0 CAP REM REMEDICA LTD SBI MASSY DISTRIBUTION (BDOS) LTD B 281292 ANTICONVULSANTS MISCELLANEOUS 2022-04-01 2024-03-31 Oral 0 CENTRAL NERVOUS SYSTEM DRUGS
40 A2324 APO-GABAPENTIN 100MG CAP (APO/COL) GABAPENTIN APO-GABAPENTIN 100'S C 9.51 0.10 CAPSULE 0 CAP APO APOTEX INC. COL COLLINS LTD 281292 ANTICONVULSANTS MISCELLANEOUS 2022-04-01 2024-03-31 Oral 0 CENTRAL NERVOUS SYSTEM DRUGS
42 A2324 APO-GABAPENTIN 100MG CAP (APO) GABAPENTIN APO-GABAPENTIN 100'S C 9.70 0.10 CAP 0 BOTT APO APOTEX INC. COL AVENTA BARBADOS 281292 ANTICONVULSANTS MISCELLANEOUS 2026-04-01 ORAL 0 ANTICONVULSANTS MISCELLANEOUS
41 A232P APO-GABAPENTIN 100MG CAP (APO) (C) GABAPENTIN APO-GABAPENTIN 100'S C 9.7 0.097 CAP 0 BOTT APO APOTEX INC. ATB ANSA TRADING BARBADOS LTD 281292 ANTICONVULSANTS MISCELLANEOUS 2024-04-01 2026-03-31 ORAL 0 ANTICONVULSANTS MISCELLANEOUS